These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 33103598)
21. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Choe W; Messinger RB; Leach E; Eckle VS; Obradovic A; Salajegheh R; Jevtovic-Todorovic V; Todorovic SM Mol Pharmacol; 2011 Nov; 80(5):900-10. PubMed ID: 21821734 [TBL] [Abstract][Full Text] [Related]
22. Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model. Gupta SK; Torrico Guzmán EA; Meenach SA Int J Cancer; 2017 Nov; 141(10):2143-2153. PubMed ID: 28771722 [TBL] [Abstract][Full Text] [Related]
23. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
24. Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel. Eshita Y; Ji RC; Onishi M; Kobayashi T; Mizuno M; Yoshida J; Kubota N; Onishi Y Drug Deliv Transl Res; 2015 Feb; 5(1):38-50. PubMed ID: 25787338 [TBL] [Abstract][Full Text] [Related]
25. T-Type Ca Visa A; Sallán MC; Maiques O; Alza L; Talavera E; López-Ortega R; Santacana M; Herreros J; Cantí C Cancer Res; 2019 Apr; 79(8):1857-1868. PubMed ID: 30755443 [TBL] [Abstract][Full Text] [Related]
26. Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo. Tan KT; Li S; Li YR; Cheng SL; Lin SH; Tung YT Appl Biochem Biotechnol; 2019 Apr; 187(4):1328-1343. PubMed ID: 30229430 [TBL] [Abstract][Full Text] [Related]
27. ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells. Feng J; Peng Z; Gao L; Yang X; Sun Z; Hou X; Li E; Zhu L; Yang H Biomed Pharmacother; 2021 Jun; 138():111407. PubMed ID: 33765585 [TBL] [Abstract][Full Text] [Related]
28. Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade. Chen MP; Cabantchik ZI; Chan S; Chan GC; Cheung YF PLoS One; 2014; 9(11):e112915. PubMed ID: 25390893 [TBL] [Abstract][Full Text] [Related]
29. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. Shen J; Yin Q; Chen L; Zhang Z; Li Y Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221 [TBL] [Abstract][Full Text] [Related]
30. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130 [TBL] [Abstract][Full Text] [Related]
31. Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression. Pan W; Wang Q; Zhang Y; Zhang N; Qin J; Li W; Wang J; Wu F; Cao L; Xu G Cell Physiol Biochem; 2016; 39(2):481-90. PubMed ID: 27383277 [TBL] [Abstract][Full Text] [Related]
32. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Wang W; Xi M; Duan X; Wang Y; Kong F Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664 [TBL] [Abstract][Full Text] [Related]
34. The Hard-To-Close Window of T-Type Calcium Channels. Visa A; Shaikh S; Alza L; Herreros J; Cantí C Trends Mol Med; 2019 Jul; 25(7):571-584. PubMed ID: 31031178 [TBL] [Abstract][Full Text] [Related]
35. Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line. Violini S; D'Ascenzo S; Bagnoli M ; Millimaggi D; Miotti S; Canevari S; Pavan A; Dolo V J Exp Clin Cancer Res; 2004 Mar; 23(1):83-91. PubMed ID: 15149155 [TBL] [Abstract][Full Text] [Related]
36. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Kumfu S; Chattipakorn S; Chinda K; Fucharoen S; Chattipakorn N Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220 [TBL] [Abstract][Full Text] [Related]
37. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720 [TBL] [Abstract][Full Text] [Related]
38. Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth. Wu ZH; Lu MK; Hu LY; Li X PLoS One; 2012; 7(12):e51721. PubMed ID: 23251610 [TBL] [Abstract][Full Text] [Related]
39. Modulating TRPV4 channels with paclitaxel and lithium. Sánchez JC; Muñoz LV; Ehrlich BE Cell Calcium; 2020 Nov; 91():102266. PubMed ID: 32871457 [TBL] [Abstract][Full Text] [Related]
40. The effects of preferential A- and C-fibre blocks and T-type calcium channel antagonist on detection of low-force monofilaments in healthy human participants. Nagi SS; Dunn JS; Birznieks I; Vickery RM; Mahns DA BMC Neurosci; 2015 Aug; 16():52. PubMed ID: 26268809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]